Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04082364
Brief Title: Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer (MAHOGANY)

First Submitted : September 5, 2019
First Submitted that Met QC Criteria : September 5, 2019
First Posted : September 9, 2019

Last Update Submitted that Met QC Criteria : July 28, 2022
Last Update Posted : August 1, 2022